Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults

NCT00890149 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT00890149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00890149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
Lead sponsor
University of Maryland, Baltimore
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2015
Completion date
March 31, 2017
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse, alcoholism